Knockdown experiments demonstrated that LLGL2 scaffolding protein regulates amino-acid induced activation of the mTOR pathway in estrogen receptor positive (ER+) breast cancer cells, and high expression of these leucine transporters were correlated with poor survival in ER+ breast cancer patients treated with tamoxifen14. The gene discussed is LLGL2; the disease is breast cancer.